Emily Claire O'Brien, PhD

Emily O'Brien

General Statement of Disclosure:

RESEARCH/RESEARCH GRANTS: Janssen Pharmaceuticals, Inc(MODEST), Bristol-Myers Squibb Company (MODEST), GlaxoSmithKline(MODEST), Novartis(SIGNIFICANT)

View Full Disclosure